Louis-David Cantin, PhD, MBA



Louis-David Cantin, PhD, MBA, is President, Groupe PARIMA, where he is responsible for developing the long-term goals as well as the strategic planning for the company. Groupe PARIMA collaborates with clients located in over 30 countries to ensure on-time supply and delivery of commercial products and drug-development services.

He possesses extensive experience in both leadership and management functions in the pharmaceutical industry. Prior to Groupe PARIMA, he held managerial positions at Bayer Healthcare and AstraZeneca, both in the US and Canada, where he occupied positions with increasing leadership responsibilities, enabling him to gain extensive knowledge of international pharmaceutical markets. This diversity of experience also enabled him to gain insights from the client’s perspective in the contract research organization/contract development and manufacturing organization) sector.

After securing his B.Sc. degree from Eckerd College (St. Petersburg, Florida), he received his PhD in organic chemistry from the Université de Montréal, which was followed by a post-doctoral research appointment at the University of Pennsylvania (Philadelphia, Pennsylvania). More recently, he completed an executive MBA program.